These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 20347057

  • 21. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
    Bilcke J, Van Damme P, Beutels P.
    Med Decis Making; 2009; 29(1):33-50. PubMed ID: 18948433
    [Abstract] [Full Text] [Related]

  • 22. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Lee H, Park SY, Clark A, Debellut F, Pecenka C, Kim DS, Kim HM, Kim JH, Cho H, Kim AY, Lee M, Jung SY, Seong BL, Kang HY.
    Vaccine; 2019 Aug 14; 37(35):4987-4995. PubMed ID: 31326252
    [Abstract] [Full Text] [Related]

  • 23. [A cost-effectiveness analysis on universal infant rotavirus vaccination strategy in China].
    Sun SL, Gao YQ, Yin J, Zhuang GH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb 14; 37(2):238-42. PubMed ID: 26917523
    [Abstract] [Full Text] [Related]

  • 24. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.
    Vaccine; 2012 Apr 27; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
    Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S16-27. PubMed ID: 19817595
    [Abstract] [Full Text] [Related]

  • 27. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.
    J Infect Dis; 2005 Nov 15; 192(10):1720-6. PubMed ID: 16235169
    [Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness of rotavirus vaccination programs in Taiwan.
    Chang WC, Yen C, Chi CL, Wu FT, Huang YC, Lin JS, Huang FC, Tate JE, Wu HS, Hsiung CA.
    Vaccine; 2013 Nov 04; 31(46):5458-65. PubMed ID: 24060569
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
    Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP.
    Vaccine; 2012 Nov 06; 30(48):6766-76. PubMed ID: 23000223
    [Abstract] [Full Text] [Related]

  • 31. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F, Barbieri M, Dirodi B, Vitali Rosati G, Franco E.
    Ann Ig; 2013 Nov 06; 25(1):43-56. PubMed ID: 23435779
    [Abstract] [Full Text] [Related]

  • 32. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia.
    Lusvan ME, Debellut F, Clark A, Demberelsuren S, Otgonbayar D, Batjargal T, Purevsuren S, Groman D, Tate J, Pecenka C.
    Vaccine; 2019 Feb 04; 37(6):798-807. PubMed ID: 30639458
    [Abstract] [Full Text] [Related]

  • 33. Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea.
    Kang HY, Kim KH, Kim JH, Kim HM, Kim J, Kim MS, El Khoury AC, Kim DS.
    Asia Pac J Public Health; 2013 Mar 04; 25(2):145-58. PubMed ID: 22234827
    [Abstract] [Full Text] [Related]

  • 34. The cost-effectiveness of rotavirus vaccination in Australia.
    Newall AT, Beutels P, Macartney K, Wood J, MacIntyre CR.
    Vaccine; 2007 Dec 17; 25(52):8851-60. PubMed ID: 18022735
    [Abstract] [Full Text] [Related]

  • 35. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands.
    Goossens LM, Standaert B, Hartwig N, Hövels AM, Al MJ.
    Vaccine; 2008 Feb 20; 26(8):1118-27. PubMed ID: 18215445
    [Abstract] [Full Text] [Related]

  • 36. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.
    Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K, Breiman RF, Feikin DR, Mintz ED, Widdowson MA.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S76-84. PubMed ID: 19817618
    [Abstract] [Full Text] [Related]

  • 37. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
    Ortega O, El-Sayed N, Sanders JW, Abd-Rabou Z, Antil L, Bresee J, Mansour A, Adib I, Nahkla I, Riddle MS.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S92-8. PubMed ID: 19817621
    [Abstract] [Full Text] [Related]

  • 38. The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe.
    Jit M, Bilcke J, Mangen MJ, Salo H, Melliez H, Edmunds WJ, Yazdan Y, Beutels P.
    Vaccine; 2009 Oct 19; 27(44):6121-8. PubMed ID: 19715781
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of rotavirus vaccination in peru.
    Clark AD, Walker DG, Mosqueira NR, Penny ME, Lanata CF, Fox-Rushby J, Sanderson CF.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S114-24. PubMed ID: 19817591
    [Abstract] [Full Text] [Related]

  • 40. Potential cost-effectiveness of a rotavirus immunization program in rural China.
    Wang XY, Riewpaiboon A, von Seidlein L, Chen XB, Kilgore PE, Ma JC, Qi SX, Zhang ZY, Hao ZY, Chen JC, Xu ZY.
    Clin Infect Dis; 2009 Oct 15; 49(8):1202-10. PubMed ID: 19739973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.